As with fluorescence microscopy, various NIR-dyes can be detected at the same time; the problem of heterogenous tumor binding of CAIX-specific nanobodies can be solved by co-injection of two or multiple probes, with specificities for other tumor markers. The gene discussed is CA9; the disease is neoplasm.